ARCHIVES

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

This article is from The Cancer Letter archive.

Vol. 06 No. 32 | August 8, 1980

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

NCAB Subcommittee Suggests Comp Centers Must Have Core Grants

September 22, 1978

Human Subject Rules Now Have forces Of Law; Already Conforming

June 7, 1974

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

August 30, 2013

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

Kaiser Foundation Offers Community Health Grants

April 18, 1986